Monoclonal Anti body therapy

Although there are several treatments being described in the above section still there are certain factors that takes the treatment to the unresponsive pathway. One such factor is the cellular heterogeneity because by the time the cancer reaches the stage of treatment the cells in the body behave heterogeneously and this factor reveals that only some cells respond to the treatment whereas certain cells remain unresponsiveness. This property of heterogeneity is due to the individual characteristics of the cell and its location on the human body. The frightening factor here is that the individual cell can develop resistance against the treatments due to their property of independency. Of course this cannot be achieved by the cell in the surgical treatment as it directly removes the cell whereas the other treatments only use the drugs. Location of the cell is also responsible for the responsiveness factor as the drugs should reach the location through general circulation.